Home » Topics » Regulatory » Patents

Patents
RSS

Natural cerebral function-improving agents from Yamanouchi

Sep. 27, 1996

Neurite outgrowth inducers presented by Kitasato Institute

Sep. 27, 1996

Egis claims new anxiolytics with a favorable side effect profile

Sep. 27, 1996

Novel MAb reported by Kyowa Hakko

Sep. 27, 1996

Lilly's antiobesity proteins

Sep. 27, 1996

Takeda reports new agent for improving lipid metabolism

Sep. 27, 1996

Nippon Shoji's newest ACAT inhibitors

Sep. 27, 1996

Kyowa Hakko describes protein inducing osteoblast proliferation

Sep. 27, 1996

Anticataract and NGF production-enhancing compounds

Sep. 27, 1996

Japanese researchers report new antiangiogenic compound

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...